Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use

Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use

US Patent 9695133 · Granted Jul 4, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic2025
Inhibitors of menin-MLL interaction2025
Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum 2025
CD16a binding agents and uses thereof2024
Substituted pyridines as irreversible inhibitors of menin-MLL interaction2024
Irreversible inhibitors of menin-MLL interaction2024
Inhibitors of menin-mll interaction2023
Substituted pyridines as irreversible inhibitors of menin-MLL interaction2023
CD16A binding agents and uses thereof2023
Compositions and methods for treating infections2022
Compounds, compositions, and methods for modulating ferroptosis and treating exc2021
Inhibitors of menin-MLL interaction2021